
Anand Anandkumar
@anand_bugworks
passionate about solving global health problems (focus on Infection, and oncology and empowering the girl child!
ID: 2599291717
http://www.bugworksresearch.com 02-07-2014 06:36:23
1,1K Tweet
1,1K Followers
438 Following

While more countries are concerned about #AMR than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics. Wellcome Anand Anandkumar Kerry Cullinan healthpolicy-watch.news/more-countries…

Given the antibacterial pipeline trends, what are the latest R&D recommendations? 💡Develop innovative medicines to combat drug-resistant Gram-negative infections, according to World Health Organization (WHO) We are proud to work with Anand Anandkumar to address this need! iris.who.int/bitstream/hand…?



Thanks Mia Amor Mottley for your leadership to #StopSuperbugs. “We have a moral responsibility to develop new accessible #antibiotics to save lives.” One Health Trust FIND Int. Centre for Antimicrobial Resistance Solutions Global AMR Research & Development (R&D) Hub Gates Foundation IFPMA Africa CDC IDSA AMR Action Fund CDC Antimicrobial Resistance #UNGA79


New report from Center for Global Development estimates: -#AMR adds excess $66 bn to global costs of hospital treatment - If AMR worsens w/o effective interventions, costs could ⬆️ $159 billion annually by 2050 -Under certain conditions, #AMR shrinks global econ by $1.7 trillion

Excellent speech by MoS Anupriya Patel #UNGA2024 in recognition of all the work done on #AMR in India by NCDC India ICMR CDSCO_INDIA_INFO FSSAI DBT-BIRAC Indian Council of Agricultural Research. and all the dedicated scientists and researchers. Some milestones achieved but miles to go!!

“We need a bold vision to support LMICs to undertake the R&D to develop new and affordable antibiotics where the biggest burden is. And by doing so, produce the necessary evidence for broader use globally.” Anand Anandkumar #WHS2024



Roads in Whitefield are pathetic and the traffic situation is iMPOSSIBLE. It takes 1-2 hours sometimes to cover 1km, struggling every day. Traffic police/BBMP/Local MLA - please help, we get NOTHING for paying taxes Whitefield Rising WHITEFIELD TRAFFIC PS BTP Manjula Aravind Limbavali Maheshwar Rao.M, IAS ನಮ್ಮ ವೈಟ್ಫೀಲ್ಡ್ Namma Whitefield


Dear Manjula Aravind Limbavali madam, when can residents of Thubarahalli meet with you to discuss the impossible traffic situation (from Vartur Kodi to Kundanahalli junction). I see ambulances being stuck almost everyday. The roads are pathetic, and we get no support from BBMP. Thanks


India Tops the Global Innovation Index in Middle Income Category 🇮🇳 Narendra Modi Rajeev Chandrasekhar 🇮🇳 Piyush Goyal Gopal Krishna Agarwal Jitin Prasada जितिन प्रसाद Prof. Krishnamurthy V Subramanian anand mahindra Mohandas Pai Nandan Nilekani KhushbuSundar Elon Musk Kiran Mazumdar-Shaw Anand Ranganathan


India's 'blockbuster' drugs to combat antibiotic-resistant superbugs Gr8 tosee C-CAMP startup #Bugworks here BBC Office of Principal Scientific Adviser to the GoI CARB-X Global Antibiotic R&D Partnership (GARDP) Anand Anandkumar NITI Aayog kris gopalakrishnan bbc.com/news/articles/…


We are ecstatic about this! 4 out of 6 Top Indian biotech companies leading the global healthcare revolution from the forefront are C-CAMP startups as per the latest Labiotech.eu survey. labiotech.eu/best-biotech/b… Congrats #Bugworks, Zumutor Biologics Eyestem #Gangagen

I always learn a ton from Kamala's reporting. Well researched and superbly written. Incidentally, Anand Anand Anandkumar, the co-founder and CEO of Bugwork Research, is a fellow CEG alum. Kudos!


Speaker Vasan Sambandamurthy from Anand Anandkumar explaining India's role in the #AntibioticEmergency- "More than 60% of the world's medicines are manufactured in India, India is the pharmacy of the world. We need to know who is buying what antibiotics so we can regulate well."


🎉 CCAMP startup Bugworks has clinched the Forbes India National Award in the Emerging Innovation category for their pioneering work in deep science. Incubated at CCAMP, Bugworks is a clinical-stage biopharmaceutical company developing affordable, accessible, and novel therapies
